VT
AZN icon

Vise Technologies’s AstraZeneca AZN Stock Holding History

Vise Technologies’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,248
Closed -$5.19M – 1450
2025
Q4 		$5.19M Buy
28,248
+13,350
+90% +$2.34M 0.1% 165
2025
Q3 		$2.29M Buy
14,898
+74
+0.5% +$11.2K 0.09% 230
2025
Q2 		$2.07M Buy
+14,824
New +$2.08M 0.09% 248
2024
Q4 		$1.44M Buy
10,991
+219
+2% +$30.7K 0.12% 179
2024
Q3 		$1.68M Buy
10,772
+2,163
+25% +$349K 0.21% 99
2024
Q2 		$1.34M Buy
8,609
+1,688
+24% +$254K 0.24% 93
2024
Q1 		$938K Buy
6,921
+471
+7% +$62.4K 0.18% 119
2023
Q4 		$869K Buy
6,450
+120
+2% +$15.6K 0.19% 123
2023
Q3 		$857K Sell
6,330
-985
-13% -$135K 0.21% 115
2023
Q2 		$1.05M Buy
7,315
+965
+15% +$142K 0.25% 92
2023
Q1 		$881K Buy
6,350
+705
+12% +$94.9K 0.23% 101
2022
Q4 		$765K Buy
5,645
+714
+14% +$89.5K 0.24% 104
2022
Q3 		$541K Buy
4,931
+245
+5% +$31.1K 0.2% 114
2022
Q2 		$619K Buy
4,686
+2,173
+86% +$285K 0.24% 103
2022
Q1 		$333K Buy
+2,513
New +$301K 0.13% 156

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Vise Technologies's AZN Position: Q1 2026 in Review

Vise Technologies sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 28,248 shares — an estimated $5.19M sold.

Vise Technologies first reported a position in AZN in Q1 2022 and held it in 15 quarters. The position peaked at $5.19M in Q4 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Vise Technologies reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Vise Technologies sold 28,248 AstraZeneca shares in Q1 2026, an estimated $5.19M.
  • Vise Technologies first reported a position in AstraZeneca in Q1 2022 and held it in 15 quarters.
  • Vise Technologies's AstraZeneca position peaked at $5.19M in Q4 2025.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.